Search for Clinical Trial Results
Epithelial-myoepithelial Carcinoma - 25 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Study to Evaluate Efficacy and Safety of Sunitinib in Patients With Renal Cell Carcinoma Who Have Progressed to First-line Immunotherapy Treatment Condition: Clear Cell Renal Carcinoma Date: 2017-02-23 Interventions: Drug: Sunitinib Sunitinib 50 mg/d |
Active, not recruiting |
Study Name: Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer Condition:
|
Completed |
Study Name: Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer Condition:
|
Completed |
Study Name: Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer Condition:
|
Completed |
Study Name: Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition:
|
Recruiting |
Study Name: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas Condition:
Date: 2012-06-19 Interventions: |
Completed |
Study Name: Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer Condition:
|
Completed |
Study Name: Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer Condition:
|
Completed |
Study Name: High-dose Bevacizumab in Advanced Renal Carcinoma Patients Condition:
Date: 2007-04-03 Interventions: Drug: Bevacizumab Bevacizumab Other Name: Avastin |
Terminated |
Study Name: A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers Condition: Uterine Cancer Date: 2005-09-30 Interventions: Drug: Celecoxib |